• Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • About
    • About Us
    • Founding Team
  • Blog
  • Drug Search
  • Zones
    • Suicide
    • Violence
    • Sex and Relationships
    • Hair
    • Skin and Nails
    • Withdrawal
    • Vision
    • Fertility
  • Research Fund
  • Tools
    • Healthcare Record Pro Forma
    • Starting a Medication
    • Guides & Papers
    • Too Many Medications?
    • Complex Withdrawal
    • Videos
    • Reducing the Risk of Treatment Induced Suicide
  • PSSD
    • Post-SSRI Sexual Dysfunction (PSSD)
    • PSSD Doctors
    • PSSD Literature
    • PSSD in the Media
    • RxISK Prize
    • Research Forum for Enduring Sexual Dysfunction
  • Side Effect?
RxISK Logo

RxISK

Making Medicines Safer for All of Us

Dr. David Healy reviews Bad Pharma

March 28, 2013 Leave a Comment

RxISK founder Dr. David Healy reviews Ben Goldacre’s Bad Pharma

Toronto, Ontario — Psychopharmacologist and world-renowned drug safety expert Dr. David Healy of RxISK.org reviews Dr. Ben Goldacre’s best seller Bad Pharma.

Healy praises many aspects of the book: “It will be accessible to anyone interested in health and its politics. It strikes the right note of outrage. It tackles the problems pharmaceutical companies pose to medical care and Evidence Based Medicine” (EBM). However, he cautions that: “The risk is that the solutions it proposes will aggravate rather than resolve our problems.”

Dr. Healy argues that fixating on randomized control trials (RCT), and mistaking this for drug safety testing, is a serious problem with the medical profession today. Ben Goldacre believes that the answer is more rigorous RCT with complete disclosure of all results. Healy points out that because RCT are inherently unsuitable for answering many important questions, the solution offered by Ben Goldacre will not cure what ails the practice of medicine. Dr. Healy insists that what is needed is for physicians to stop depending on EBM (which is in turn based on flawed RCT) and return to listening carefully to their patients, and exercising clinical judgment and discretion. As Dr. Healy says “The plural of clinical trials is not medicine”.

Here is the complete review.

About Data Based Medicine Global Ltd.

RxISK.org is owned and operated by Data Based Medicine Global Ltd. (DBM). DBM’s founders have international reputations in early drug-side-effect detection and risk mitigation, pharmacovigilance, and patient-centered care. Although drug side effects are known to be a leading cause of death and disability, less than 5% of serious drug side effects are reported. DBM’s mission is to capture this missing data directly from patients through RxISK’s free drug side effect reporting tool and use this data to help make medicines safer for all of us.

Filed Under: News

Are you experiencing a drug side effect?

Get your free RxISK Report to find out

 

Subscribe to our mailing list
Get notified when we publish a new blog post.
By subscribing, you agree with our privacy policy and our terms of service.

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

Recent Posts

  • Who Knew Drugs could have Antibodies
  • Ostriches, Doctors, SSRIs and Tylenol
  • Withdrawal Syndromes: Lost in Translation
  • Over-Diagnosing or Under-Diagnosing
  • The Future of Health App-ointments

Blog Categories

Footer

Contact

Media Contact

Terms | Privacy

Follow us

  • Facebook
  • Twitter

Search

Copyright © 2025 · Data Based Medicine Global Ltd.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok